Oncolytics Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.40

-0.01 (-2.58%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +4,934.9% upside

Low Target $14.44

Average Target $20.19

High Target $28.89

Current Price $0.40

Current
$0.40

Target
$20.19

$14.44 $20.19 avg $28.89

Scenario Analysis

Bear Case

$14.44

3,501.0%

Low target

Base Case

$20.19

+4,934.9%

Avg target

Bull Case

$28.89

+7,104.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$4.49

-91.1% from high

52-Week Low

$1.48

+-72.9% from low

Target vs 52W High

$20.19

+349.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%